Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors

References

• Feinstein A R, Krause A C. Ocular involvement in lymphomatous disease. AMA Arch Ophthalmol 1952; 48: 328–337
   PubMed Web of Science ®Google Scholar
• Fitzpatrick P J, Macko S. Lymphoreticular tumors of the orbit. Int J Radiat Oncol Biol Phys 1984; 10: 333–340
   PubMed Web of Science ®Google Scholar
• Lambo M J, Brady L W, Shields C L. Lymphoid tumors of the orbit. Radiotherapy of Intraocular and Orbital Tumors, W E Alberti, R H Sagerman. Springer-Verlag, Berlin 1993; 205–216
   Google Scholar
• Margo C E, Mulla Z D. Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology 1998; 105: 185–190
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Diébold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting – Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Oken M M, Creech R H, Tormey D C, Horton J, Davis T E, McFadden E T, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–655
   PubMed Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• Shipp M A, Harrington D P, Anderson J R, et al. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Cheson B D, Horning J S, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244–1253
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Cox D R. Regression models and life tables. J Roy Stat Soc 1972; 34: 187–220
   Google Scholar
• Knowles D M, Jakobiec F A, McNally L, Burke J S. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol 1990; 21: 959–973
   PubMed Web of Science ®Google Scholar
• Nakata M, Matsumo Y, Katsumata N, Takenaka T, Kobayashi Y, Narabayashi M, et al. Histology according to the Revised European-American Lymphoma classification significantly predicts the prognosis of ocular adnexal lymphoma. Leuk Lymphoma 1999; 32: 533–543
   PubMed Web of Science ®Google Scholar
• Auw-Haedrich C, Coupland S E, Kapp A, Schmitt-Graff A, Buchen R, Witschel H. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Br J Ophthalmol 2001; 85: 63–69
   PubMed Web of Science ®Google Scholar
• Adachi A, Tamaru J -I, Kaneko K, Kuroda H, Miura I, Kojima T, et al. No evidence of a correlation between BCL10 expression API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma. Pathol Intern 2004; 54: 16–25
   PubMed Web of Science ®Google Scholar
• Johnson T E, Tse D T, Byrne G E, Restrepo A, Whitcomb C C, Voigt W, et al. Ocular-adnexal lymphoid tumors: a clinicopathologic and molecular genetic study of 77 patients. Ophthal Plast Reconstr Surg 1999; 15: 171–179
   PubMed Web of Science ®Google Scholar
• Shields C L, Shields J A, Carvalho C, Rundle P, Smith A F. Conjunctival lymphoid tumors: clinical analysis of 117 cases and relationship to systemic lymphoma. Ophthalmology 2001; 108: 979–984
   PubMed Web of Science ®Google Scholar
• Bessell E M, Henk J M, Wright J E, Whitelocke R A. Orbital and conjunctival lymphoma treatment and prognosis. Radiother Oncol 1988; 13: 237–244
   PubMed Web of Science ®Google Scholar
• White W L, Ferry J A, Harris N L, Grove A S, Jr. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology 1995; 102: 1994–2006
   PubMed Web of Science ®Google Scholar
• Esik O, Ikeda H, Mukai K, Kaneko A. A retrospective analysis of different modalities for treatment of primary orbital non-hodgkin's lymphomas. Radiother Oncol 1996; 38: 13–18
   PubMed Web of Science ®Google Scholar
• Restrepo A, Raez L E, Byrne G E, Jr, Johnson T, Ossi P, Benedetto P, et al. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?. Crit Rev Oncog 1998; 9: 269–273
   PubMed Web of Science ®Google Scholar
• Bhatia S, Paulino A C, Buatti J M, Mayr N A, Wen B C. Curative radiotherapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 2002; 54: 818–823
   PubMed Web of Science ®Google Scholar
• Cho E Y, Han J J, Ree H J, Ko Y H, Kang Y K, Ahn H S, et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am J Hematol 2003; 73: 87–96
   PubMed Web of Science ®Google Scholar
• Fung C Y, Tarbell N J, Lucarelli M J, Goldberg S I, Linggood R M, Harris N L, et al. Ocular adnexal lymphoma: clinical behavior of distinct WHO classification subtypes. Int J Radiat Oncol Biol Phys 2003; 57: 1382–1391
   PubMed Web of Science ®Google Scholar
• Jenkins C, Rose G E, Bunce C, Cree I, Norton A, Plowman P N, et al. Clinical features associated with survival of patients with lymphoma of the ocular adnexa. Eye 2003; 17: 809–820
   PubMed Web of Science ®Google Scholar
• Martinet S, Ozsahin M, Belkacemi Y, Landmann C, Poortmans P, Oehlere C, et al. Outcome and prognostic factors in orbital lymphoma: a rare cancer network study on 90 consecutive patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 892–898
   PubMed Web of Science ®Google Scholar
• Uno T, Isobe K, Shikama N, Nishikawa A, Oguchi M, Ueno N, et al. Radiotherapy for extranodal, marginal-zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa. Cancer 2003; 98: 865–871
   PubMed Web of Science ®Google Scholar
• Coupland S E, Hellmich M, Auw-Haedrich C, Lee W R, Stein H. Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases. Graefes Arch Clin Exp Ophthalmol 2004; 242: 130–145
   PubMed Web of Science ®Google Scholar
• Glass A G, Karnell L H, Menck H R. Data base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311–2320
   PubMed Web of Science ®Google Scholar
• Thiéblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806
   PubMed Web of Science ®Google Scholar
• Tsang R W, Gospodarowicz M K, Pintilie M, Wells W, Hodgson D C, Sun A, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157–4164
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Pedrinis E. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489–2495
   PubMed Web of Science ®Google Scholar
• Jereb B, Lee H, Jakobiec F A, Kutcher J. Radiation therapy of conjunctival and orbital lymphoid tumors. Int J Radiat Oncol Biol Phys 1984; 10: 1013–1019
   PubMed Web of Science ®Google Scholar
• Coupland S E, Krause L, Delecluse H J, Anagnostopoulos I, Foss H D, Hummel M, et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology 1998; 105: 1430–1441
   PubMed Web of Science ®Google Scholar
• Bolek T W, Moyses H M, Marcus R B, Jr, Gorden L, 3rd, Maiese R L, Almasri N M, et al. Radiotherapy in the management of orbital lymphoma. Int J Radiat Oncol Biol Phys 1999; 44: 31–36
   PubMed Web of Science ®Google Scholar
• Jenkins C, Rose G E, Bunce C, et al. Histological features of ocular adnexal lymphoma (REAL classification) and their association with patient morbidity and survival. Br J Ophthalmol 2000; 84: 907–913
   PubMed Web of Science ®Google Scholar
• Blasi M A, Gherlinzoni F, Calvisi G, Sasso P, Tani M, Cellini M, et al. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 2001; 108: 559–552
   PubMed Web of Science ®Google Scholar
• Nuckel H, Meller D, Steuhl K P, Duhrsen U. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva. Eur J Haematol 2004; 73: 258–262
   PubMed Web of Science ®Google Scholar
• Zinzani P L, Alinari L, Stefoni V, Loffredo A, Pichierri P, Polito E. Rituximab in primary conjunctiva lymphoma. Leuk Res 2005; 29: 107–108
   PubMed Web of Science ®Google Scholar
• Matsuo T, Yoshino T. Long-term follow-up results of observation or radiation for conjunctival malignant lymphoma. Ophthalmology 2004; 111: 1233–1237
   PubMed Web of Science ®Google Scholar